Vivos Therapeutics, Inc. SEC filings VVOS

Vivos Therapeutics, Inc. has 301 filings in SEC EDGAR's recent list, going back to Sep 28, 2017. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Vivos Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 21, 2026 Oct 20, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Oct 19, 2026 Oct 15, 2026
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 15, 2026 Oct 14, 2026
8-K Current report
Auditor change
Oct 1, 2026 Sep 29, 2026
8-K/A Amended current report
Material agreement, Unregistered share sale
Sep 8, 2026 Sep 2, 2026
8-K Current report
Material agreement, Unregistered share sale
Sep 8, 2026 Aug 31, 2026
8-K Current report
Regulation FD disclosure
Aug 21, 2026 Aug 20, 2026
8-K Current report
Regulation FD disclosure
Aug 11, 2026 Aug 5, 2026
8-K Current report
Material agreement, Officer or director change
Aug 3, 2026 Jul 31, 2026
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Jul 7, 2026 Jul 7, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jun 25, 2026 Jun 25, 2026
8-K Current report
Other events
Jun 16, 2026 Jun 16, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jun 16, 2026 Jun 15, 2026
8-K Current report
Material agreement, New debt, Listing notice, Unregistered share sale, Regulation FD disclosure
Jun 8, 2026 Jun 8, 2026
8-K Current report
Listing notice
Apr 22, 2026 Apr 22, 2026
8-K Current report
Results of operations
Apr 15, 2026 Apr 15, 2026
8-K Current report
Material agreement, Unregistered share sale
Apr 3, 2026 Apr 3, 2026
8-K Current report
Officer or director change
Feb 6, 2026 Feb 6, 2026
8-K Current report
Material agreement, Unregistered share sale
Jan 20, 2026 Jan 20, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Jan 16, 2026 Jan 16, 2026
8-K Current report
Other events
Dec 17, 2025 Dec 16, 2025
8-K Current report
Material agreement, New debt
Dec 5, 2025 Dec 5, 2025
8-K Current report
Results of operations
Nov 19, 2025 Nov 19, 2025
8-K Current report
Shareholder vote results
Nov 4, 2025 Nov 4, 2025
8-K Current report
Other events
Oct 24, 2025 Oct 24, 2025
8-K Current report
Other events
Sep 18, 2025 Sep 17, 2025
8-K Current report
Other events
Sep 12, 2025 Sep 12, 2025
8-K/A Amended current report
Acquisition or sale of assets, Other events
Aug 25, 2025 Jun 9, 2025
8-K Current report
Results of operations
Aug 20, 2025 Aug 20, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 13, 2025 Jun 13, 2025
8-K Current report
Auditor change
Jun 6, 2025 Jun 6, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
May 23, 2025 May 23, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
8-K Current report
Material agreement
Apr 17, 2025 Apr 17, 2025
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Material agreement, Officer or director change
Feb 14, 2025 Feb 14, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 23, 2024 Dec 23, 2024
8-K Current report
Shareholder vote results
Nov 27, 2024 Nov 27, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 20, 2024 Sep 20, 2024
8-K Current report
Other events
Sep 18, 2024 Sep 18, 2024
8-K Current report Sep 17, 2024 Sep 17, 2024
8-K Current report
Officer or director change
Sep 12, 2024 Sep 12, 2024
8-K Current report
Results of operations
Aug 15, 2024 Aug 14, 2024
8-K Current report
Other events
Jul 10, 2024 Jul 10, 2024
8-K Current report
Other events
Jun 25, 2024 Jun 25, 2024
8-K Current report
Material agreement, Unregistered share sale
Jun 14, 2024 Jun 14, 2024
8-K Current report
Listing notice
May 17, 2024 May 17, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
8-K Current report
Other events
May 6, 2024 May 3, 2024
8-K Current report
Results of operations
Mar 29, 2024 Mar 28, 2024
8-K Current report
Material agreement, Unregistered share sale
Feb 15, 2024 Feb 15, 2024
8-K Current report
Other events
Nov 30, 2023 Nov 30, 2023
8-K Current report
Material agreement, Unregistered share sale
Nov 2, 2023 Nov 2, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Oct 27, 2023 Oct 27, 2023
8-K Current report
Shareholder vote results
Sep 25, 2023 Sep 25, 2023
8-K Current report
Listing notice
Sep 21, 2023 Sep 21, 2023
8-K Current report
Listing notice
Aug 21, 2023 Aug 21, 2023
8-K Current report
Results of operations
Aug 16, 2023 Aug 16, 2023
8-K Current report
Results of operations
Jun 8, 2023 Jun 8, 2023
8-K Current report
Listing notice
May 26, 2023 May 26, 2023
8-K Current report
Auditor change, Other events
May 9, 2023 May 9, 2023
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
8-K Current report
Listing notice
Mar 27, 2023 Mar 27, 2023
8-K Current report
Other events
Mar 2, 2023 Mar 2, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 9, 2023 Jan 9, 2023
8-K Current report
Results of operations
Dec 20, 2022 Dec 20, 2022
8-K Current report
Listing notice
Nov 29, 2022 Nov 29, 2022
8-K Current report
Results of operations, Restatement
Nov 22, 2022 Nov 22, 2022
8-K Current report
Listing notice
Nov 4, 2022 Nov 4, 2022
8-K Current report
Shareholder vote results
Aug 26, 2022 Aug 26, 2022
8-K Current report
Other events
Jul 18, 2022 Jul 15, 2022
8-K Current report
Other events
Jun 15, 2022 Jun 15, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
8-K Current report
Officer or director change
Mar 1, 2022 Mar 1, 2022
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
8-K Current report
Material agreement, Officer or director change
Sep 27, 2021 Sep 27, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
8-K Current report
Shareholder vote results
Jul 29, 2021 Jul 29, 2021
8-K Current report Jun 17, 2021 Jun 17, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
8-K Current report
Material agreement
May 12, 2021 May 12, 2021
8-K Current report
Other events
Apr 2, 2021 Apr 2, 2021
8-K Current report
Results of operations
Mar 25, 2021 Mar 25, 2021
8-K Current report
Material agreement
Feb 19, 2021 Feb 19, 2021
8-K Current report
Material agreement
Dec 15, 2020 Dec 15, 2020

Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
VVOS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Littleton, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1716166
Former names
Vivos BioTechnologies, Inc. (until Sep 29, 2017)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.